Annual FCF
-$181.86 M
-$92.09 M-102.59%
November 30, 2024
Summary
- As of February 8, 2025, NRIX annual free cash flow is -$181.86 million, with the most recent change of -$92.09 million (-102.59%) on November 30, 2024.
- During the last 3 years, NRIX annual FCF has fallen by -$91.83 million (-102.00%).
- NRIX annual FCF is now -17219.71% below its all-time high of -$1.05 million, reached on November 30, 2019.
Performance
NRIX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$50.86 M
-$6.33 M-14.22%
November 30, 2024
Summary
- As of February 8, 2025, NRIX quarterly free cash flow is -$50.86 million, with the most recent change of -$6.33 million (-14.22%) on November 30, 2024.
- Over the past year, NRIX quarterly FCF has dropped by -$6.02 million (-13.43%).
- NRIX quarterly FCF is now -225.24% below its all-time high of $40.61 million, reached on February 29, 2020.
Performance
NRIX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$181.86 M
-$74.96 M-70.12%
November 30, 2024
Summary
- As of February 8, 2025, NRIX TTM free cash flow is -$181.86 million, with the most recent change of -$74.96 million (-70.12%) on November 30, 2024.
- Over the past year, NRIX TTM FCF has dropped by -$97.98 million (-116.83%).
- NRIX TTM FCF is now -547.84% below its all-time high of $40.61 million, reached on February 29, 2020.
Performance
NRIX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
NRIX Free Cash Flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -102.6% | -13.4% | -116.8% |
3 y3 years | -102.0% | -0.3% | -2.9% |
5 y5 years | -10000.0% | -0.3% | -2.9% |
NRIX Free Cash Flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -102.6% | at low | -311.0% | at low | -116.8% | at low |
5 y | 5-year | <-9999.0% | at low | -225.2% | at low | -547.8% | at low |
alltime | all time | <-9999.0% | at low | -225.2% | at low | -547.8% | at low |
Nurix Therapeutics Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Nov 2024 | -$181.86 M(+102.6%) | -$50.86 M(+14.2%) | -$181.86 M(+70.1%) |
Aug 2024 | - | -$44.52 M(+6.9%) | -$106.90 M(+0.9%) |
May 2024 | - | -$41.64 M(-7.1%) | -$105.97 M(+26.3%) |
Feb 2024 | - | -$44.84 M(-286.0%) | -$83.87 M(-6.6%) |
Nov 2023 | -$89.77 M(-47.8%) | $24.10 M(-155.3%) | -$89.77 M(-41.9%) |
Aug 2023 | - | -$43.59 M(+123.0%) | -$154.39 M(-3.8%) |
May 2023 | - | -$19.55 M(-61.5%) | -$160.52 M(-9.1%) |
Feb 2023 | - | -$50.73 M(+25.2%) | -$176.68 M(+2.7%) |
Nov 2022 | -$172.05 M | -$40.52 M(-18.5%) | -$172.05 M(+5.4%) |
Aug 2022 | - | -$49.73 M(+39.3%) | -$163.30 M(+12.3%) |
May 2022 | - | -$35.70 M(-22.6%) | -$145.41 M(+1.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Feb 2022 | - | -$46.10 M(+45.1%) | -$143.34 M(+59.2%) |
Nov 2021 | -$90.03 M(+1843.1%) | -$31.77 M(-0.2%) | -$90.03 M(+13.0%) |
Aug 2021 | - | -$31.84 M(-5.3%) | -$79.64 M(+43.2%) |
May 2021 | - | -$33.63 M(-566.4%) | -$55.62 M(+46.2%) |
Feb 2021 | - | $7.21 M(-133.7%) | -$38.03 M(+720.9%) |
Nov 2020 | -$4.63 M(+341.2%) | -$21.39 M(+173.8%) | -$4.63 M(-127.7%) |
Aug 2020 | - | -$7.81 M(-51.3%) | $16.75 M(-31.8%) |
May 2020 | - | -$16.04 M(-139.5%) | $24.57 M(-39.5%) |
Feb 2020 | - | $40.61 M | $40.61 M |
Nov 2019 | -$1.05 M(-96.8%) | - | - |
Nov 2018 | -$33.27 M | - | - |
FAQ
- What is Nurix Therapeutics annual free cash flow?
- What is the all time high annual FCF for Nurix Therapeutics?
- What is Nurix Therapeutics annual FCF year-on-year change?
- What is Nurix Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Nurix Therapeutics?
- What is Nurix Therapeutics quarterly FCF year-on-year change?
- What is Nurix Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Nurix Therapeutics?
- What is Nurix Therapeutics TTM FCF year-on-year change?
What is Nurix Therapeutics annual free cash flow?
The current annual FCF of NRIX is -$181.86 M
What is the all time high annual FCF for Nurix Therapeutics?
Nurix Therapeutics all-time high annual free cash flow is -$1.05 M
What is Nurix Therapeutics annual FCF year-on-year change?
Over the past year, NRIX annual free cash flow has changed by -$92.09 M (-102.59%)
What is Nurix Therapeutics quarterly free cash flow?
The current quarterly FCF of NRIX is -$50.86 M
What is the all time high quarterly FCF for Nurix Therapeutics?
Nurix Therapeutics all-time high quarterly free cash flow is $40.61 M
What is Nurix Therapeutics quarterly FCF year-on-year change?
Over the past year, NRIX quarterly free cash flow has changed by -$6.02 M (-13.43%)
What is Nurix Therapeutics TTM free cash flow?
The current TTM FCF of NRIX is -$181.86 M
What is the all time high TTM FCF for Nurix Therapeutics?
Nurix Therapeutics all-time high TTM free cash flow is $40.61 M
What is Nurix Therapeutics TTM FCF year-on-year change?
Over the past year, NRIX TTM free cash flow has changed by -$97.98 M (-116.83%)